GENETICALLY ENGINEERED VRL-LOADED ENDOTHELIAL CELLS EXPRESSING FGFR1/TRAIL/APO-2L CAUSED APOPTOTIC-INDUCED DRUG DELIVERY (AIDD) LEADING TO BYSTANDER KILLING EFFECT IN CHEMORESISTANT OVARIAN CARCINOMA CHARACTERISED BY OVER- EXPRESSION OF MDR-1 AND BCL-2
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address